| Mr. Michael Mussallem |
Non-Executive Chairman of the Board |
70 |
$13.99M - USD |
Male |
|
| Mr. Bernard Zovighian |
President, Chief Executive Officer |
55 |
$3.338M - USD |
Male |
|
| Mr. Scott Ullem |
Chief Financial Officer, Corporate Vice President |
56 |
$3.861M - USD |
Male |
|
| Mr. Jean-Luc Lemercier |
Corporate Vice President, EMEA (Europe, Middle East and Africa) |
65 |
$5.911M - USD |
Male |
|
| Mr. Donald Bobo |
Corporate Vice President - Strategy and Corporate Development |
61 |
$3.266M - USD |
Male |
|
| Mr. Daveen Chopra |
Corporate Vice President - Surgical Structural Heart |
44 |
- |
Male |
|
| Ms. Catherine Szyman |
Corporate Vice President - Critical Care |
56 |
$2.795M - USD |
Female |
|
| Mr. Larry Wood |
Corporate Vice President - Transcatheter Aortic Valve Replacement |
57 |
$3.557M - USD |
Male |
|
| Ms. Martha Marsh |
Lead Independent Director |
74 |
$364.9K - USD |
Female |
|
| Mr. Kieran Gallahue |
Independent Director |
59 |
$335.0K - USD |
Male |
|
| Ms. Leslie Heisz |
Independent Director |
62 |
$352.4K - USD |
Female |
|
| Mr. Paul Laviolette |
Independent Director |
65 |
$329.9K - USD |
Male |
|
| Mr. Steven Loranger |
Independent Director |
71 |
$335.0K - USD |
Male |
|
| Ms. Ramona Sequeira |
Independent Director |
57 |
$334.9K - USD |
Female |
|
| Mr. Nicholas Valeriani |
Independent Director |
66 |
$347.9K - USD |
Male |
|
